Stocks finished sharply lower Monday as investors weighed how rising COVID-19 cases might affect the economic recovery in the U.S. and globally.
Here are some of the top gainers for Monday:
1. SPX Flow | Increase 22%
The most recent bid was $85 a share, which SPX rebuffed on June 21. On May 27, SPX Flow had turned down an offer of $81.50 a share from Ingersoll Rand.
2. Five9 | Increase 5.9%
The purchase expands Zoom's total addressable market, including individual and enterprise customers, by around $24 billion.
3. Cytokinetics | Increase 40%
Cytokinetics (CYTK) - Get Report leaped after the biopharma reported positive results from a Phase 2 trial of its heart disease treatment and said the results supported progression to a Phase 3 trial.
The company unveiled positive top-line results from Cohorts 1 and 2 of CK-274, which is being developed to treat hypertrophic cardiomyopathy.
4. NRx Pharmaceuticals | Increase 45%
Cytokine storm occurs when an infection triggers the immune system to flood the bloodstream with inflammatory proteins called cytokines, which can kill tissue and damage organs.
5. Chewy | Increase 6.8%
Last month, Chewy swung to a surprise fiscal first-quarter profit from a year-earlier loss on 32% higher revenue.